Route of administration influences the concentration of ivermectin reaching nematode parasites in the gastrointestinal tract of cattle.
Cattle
Cooperia
Ivermectin
Ostertagia
Pharmacology
Journal
International journal for parasitology. Drugs and drug resistance
ISSN: 2211-3207
Titre abrégé: Int J Parasitol Drugs Drug Resist
Pays: Netherlands
ID NLM: 101576715
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
02
12
2019
revised:
18
10
2020
accepted:
19
10
2020
pubmed:
30
10
2020
medline:
21
8
2021
entrez:
29
10
2020
Statut:
ppublish
Résumé
An animal trial was conducted to measure the concentrations of ivermectin occurring in abomasal and small intestinal contents and mucosa, and in the target parasites (Ostertagia ostertagi and Cooperia oncophora) following administration by subcutaneous, oral and pour-on routes. Twenty-five steers were infected with ivermectin-resistant isolates of O. ostertagi and C. oncophora and following patency randomly allocated to 3 treatment groups of 7 and 1 untreated control group of four. On day 0, animals in the treatment groups were administered ivermectin via the oral, injectable or pour-on routes. On days 1, 2, 3, 4, 5, 6 and 8, blood samples were collected from all live animals, one animal from each treatment group was euthanised and the abomasum and small intestine recovered. Control animals were euthanised on each of days 4, 5, 6 and 8. Samples of gastrointestinal tract organs, their contents, mucosa and parasites were collected and assayed for ivermectin concentration using HPLC. The highest plasma concentrations occurred following subcutaneous administration. In the gastrointestinal contents the highest levels occurred following oral administration, although one high value occurred following pour-on administration, which was attributed to self-licking by the treated animal. The lowest GI content levels followed subcutaneous injection. Ivermectin concentrations in the gastrointestinal mucosa were highest following subcutaneous injection. Drug levels in the abomasal parasite O. ostertagi were most closely correlated with levels in the abomasal mucosa whereas levels in the intestinal C. oncophora were most closely correlated with those in the intestinal contents. Thus, the maximun levels of drug reached C. oncophora in the small intestine following oral administration. In contrast, the highest levels of ivermectin in O. ostertagi followed subcutaneous injection. Therefore, route of administration is likely to influence the exposure to ivermectin for different parasite species.
Identifiants
pubmed: 33120249
pii: S2211-3207(20)30038-5
doi: 10.1016/j.ijpddr.2020.10.006
pmc: PMC7591328
pii:
doi:
Substances chimiques
Anthelmintics
0
Ivermectin
70288-86-7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
152-158Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Références
Vet Parasitol. 2018 May 30;256:43-49
pubmed: 29887029
Vet Parasitol. 2005 Oct 10;133(1):61-70
pubmed: 15994007
Trends Parasitol. 2014 Jul;30(7):361-7
pubmed: 24888669
Vet Res Commun. 1985 Sep;9(4):251-68
pubmed: 3841626
Onderstepoort J Vet Res. 1978 Mar;45(1):29-37
pubmed: 704042
Vet Rec. 2015 May 23;176(21):546
pubmed: 25762583
Res Vet Sci. 2016 Apr;105:160-4
pubmed: 27033926
Int J Parasitol. 2004 Oct;34(11):1299-307
pubmed: 15491592
Vet Parasitol. 2019 Feb;266:73-79
pubmed: 30736951
Parasitol Today. 1995 Feb;11(2):56-63
pubmed: 15275374
Vet Rec. 2009 May 9;164(19):603-4
pubmed: 19429944
Aust Vet J. 2010 Dec;88(12):504-9
pubmed: 21091463
Vet Parasitol. 2014 Jul 30;204(1-2):44-54
pubmed: 24439840
N Z Vet J. 2017 Jul;65(4):176-184
pubmed: 28415922
Int J Parasitol. 1999 Jan;29(1):77-91; discussion 93-4
pubmed: 10048821
Vet Parasitol. 2000 Dec 20;94(1-2):75-89
pubmed: 11078946
Vet Res. 2003 Jul-Aug;34(4):445-60
pubmed: 12911861
Vet Parasitol. 2013 Jan 31;191(3-4):293-300
pubmed: 23063773
Exp Parasitol. 2006 May;113(1):49-57
pubmed: 16430886
Vet Parasitol. 2010 Nov 24;174(1-2):72-6
pubmed: 20851527
Exp Parasitol. 2012 Jul;131(3):304-9
pubmed: 22575734
Int J Parasitol. 2011 Apr;41(5):563-9
pubmed: 21232538
Vet Parasitol. 2016 Aug 30;227:85-92
pubmed: 27523943
Vet Parasitol. 2017 Aug 30;243:29-35
pubmed: 28807306
Vet Parasitol. 2016 Oct 15;229:139-143
pubmed: 27809969
Vet Parasitol. 2010 May 28;170(1-2):120-6
pubmed: 20181429
Vet Parasitol. 2014 Jan 17;199(1-2):81-92
pubmed: 24144515
Front Vet Sci. 2018 Oct 16;5:255
pubmed: 30386785
Vet Parasitol. 2010 Jun 24;170(3-4):224-9
pubmed: 20347229
Vet Parasitol. 2009 Mar 9;160(1-2):109-15
pubmed: 19062191
J Econ Entomol. 1977 Jun 15;70(3):319-23
pubmed: 874142
J Vet Pharmacol Ther. 1988 Sep;11(3):260-8
pubmed: 3184266
Trends Parasitol. 2011 Apr;27(4):176-81
pubmed: 21168366
Vet Parasitol. 2015 May 30;210(1-2):53-63
pubmed: 25841863
Vet Parasitol. 2000 Feb 1;87(4):327-38
pubmed: 10669102
Vet Parasitol. 2005 Mar 31;128(3-4):251-60
pubmed: 15740862
Vet Parasitol. 2017 Mar 15;236:62-67
pubmed: 28288767
Int J Parasitol Drugs Drug Resist. 2015 Aug 18;5(3):163-71
pubmed: 26448902
Res Vet Sci. 1995 May;58(3):286-7
pubmed: 7659858
Vet Parasitol. 1993 Jul;49(1):17-26
pubmed: 8236734
Trends Parasitol. 2007 Mar;23(3):97-104
pubmed: 17236810
Mol Biochem Parasitol. 1990 Jun;41(2):153-65
pubmed: 2398915
Vet Parasitol. 2009 Sep 16;164(1):70-9
pubmed: 19414223
N Z Vet J. 2001 Aug;49(4):133-7
pubmed: 16032180
N Z Vet J. 2015 Jul;63(4):227-34
pubmed: 25689407
J Chromatogr B Biomed Appl. 1995 Dec 1;674(1):119-24
pubmed: 8749259